Pricing Log in Create free account

MBody AI Ltd. (MBAI) vs Precipio, Inc. (PRPO)

MBody AI Ltd. and Precipio, Inc. are both Diagnostics & Research companies. MBody AI Ltd. is the larger, with a market value of $47.4M against $40.4M — 1.2× the size. MBody AI Ltd. has the higher net margin (0.00% vs −4.47%) and the higher return on invested capital (0.00% vs −7.63%). Across the 14 metrics below, MBody AI Ltd. leads on 8 and Precipio, Inc. on 6.

Valuation

Metric MBAI PRPO Diagnostics & Research median
P/E n/m n/m 35.56
P/S n/m 1.41 4.37
P/B 0.61 2.59 3.06
Price to free cash flow n/m 48.43 35.76
EV/EBITDA n/m 122.01 24.35
EV/Sales n/m 1.33 5.51
Earnings yield (763.41%) (2.99%) (1.89%)
Free cash flow yield (565.34%) 2.06% (0.15%)

Profitability

Metric MBAI PRPO Diagnostics & Research median
Gross margin 0.00% 44.11% 50.89%
Operating margin 0.00% (5.68%) (8.57%)
Net margin 0.00% (4.47%) (6.37%)
Free cash flow margin 0.00% 2.90% 0.00%
Return on equity 0.00% (8.98%) (2.92%)
Return on assets 0.00% (6.05%) (6.71%)
Return on invested capital 0.00% (7.63%) 0.00%

Growth

Metric MBAI PRPO Diagnostics & Research median
Revenue growth (TTM) — 28.04% 7.69%
EPS growth (last fiscal year) 115.35% 92.15% 25.92%
Revenue growth, 5-year CAGR — 31.60% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBAI PRPO Diagnostics & Research median
Debt to equity 0.00 0.07 0.11
Current ratio 0.71 1.77 2.02
Net debt to EBITDA 0.09 (3.30) 0.70

Dividend

Metric MBAI PRPO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric MBAI PRPO Diagnostics & Research median
Market cap 47.41m 40.35m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack